 Medscape | Liposomal Vincristine 'Appears to Be a Step Forward' Medscape ... collaboration with the German High-Grade Non-Hodgkin's Lymphoma Study Group and will directly compare the activity of VSLI and standard vincristine administered as part of the R-CHOP regimen (rituximab plus cyclophosphamide, hydroxydaunorubicin, ... |
